Skip to content

Clinical trials

Terminated Phase 2 Leukemia, Megakaryoblastic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Megakaryoblastic, Acute Phase: Phase 2 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20082
20091
20101
20111
20121
20142
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Roswell Park Cancer Institute3
National Cancer Institute (NCI)2
Alliance for Clinical Trials in Oncology1
Masonic Cancer Center, University of Minnesota1
Steven E. Coutre1
The Cleveland Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Erythroblastic, Acute12
Leukemia, Megakaryoblastic, Acute12
Leukemia, Myeloid, Acute12
Congenital Abnormalities11
Leukemia, Monocytic, Acute11
Leukemia, Myelomonocytic, Acute10
Leukemia4
Anemia, Refractory, with Excess of Blasts3
Myelodysplastic Syndromes3
Leukemia, Basophilic, Acute2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.